Isolation of a potential antitumor fraction from Rumex hymenosepalus

Jack R. Cole; Leonard Buchalter

doi:10.1002/jps.2600540933

Isolation of a potential antitumor fraction from Rumex hymenosepalus

Jack R. Cole, Leonard Buchalter

Pharmacy Practice and Science

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Extracts of Rumex hymenosepalus have shown antitumor activity against the Sarcoma 180 and Walker 256 test systems of the Cancer Chemotherapy National Service Center, Bethesda, Md. The extracts have been fractionated by means of solvent extraction and paper chromatography into two distinct fractions. The partial characterization of these fractions is described, including the characterization of leucocyanidin as one of the constituents and the identification of benzoic acid as a hydrolysis product of a polyphenolic ester.

Original language	English (US)
Pages (from-to)	1376-1378
Number of pages	3
Journal	Journal of pharmaceutical sciences
Volume	54
Issue number	9
DOIs	https://doi.org/10.1002/jps.2600540933
State	Published - Sep 1965

ASJC Scopus subject areas

Pharmaceutical Science

Access to Document

10.1002/jps.2600540933

Cite this

@article{c56971aef196476791f6cf06eee9d94a,

title = "Isolation of a potential antitumor fraction from Rumex hymenosepalus",

abstract = "Extracts of Rumex hymenosepalus have shown antitumor activity against the Sarcoma 180 and Walker 256 test systems of the Cancer Chemotherapy National Service Center, Bethesda, Md. The extracts have been fractionated by means of solvent extraction and paper chromatography into two distinct fractions. The partial characterization of these fractions is described, including the characterization of leucocyanidin as one of the constituents and the identification of benzoic acid as a hydrolysis product of a polyphenolic ester.",

author = "Cole, {Jack R.} and Leonard Buchalter",

year = "1965",

month = sep,

doi = "10.1002/jps.2600540933",

language = "English (US)",

volume = "54",

pages = "1376--1378",

journal = "Journal of pharmaceutical sciences",

issn = "0022-3549",

publisher = "John Wiley and Sons Inc.",

number = "9",

}

TY - JOUR

T1 - Isolation of a potential antitumor fraction from Rumex hymenosepalus

AU - Cole, Jack R.

AU - Buchalter, Leonard

PY - 1965/9

Y1 - 1965/9

N2 - Extracts of Rumex hymenosepalus have shown antitumor activity against the Sarcoma 180 and Walker 256 test systems of the Cancer Chemotherapy National Service Center, Bethesda, Md. The extracts have been fractionated by means of solvent extraction and paper chromatography into two distinct fractions. The partial characterization of these fractions is described, including the characterization of leucocyanidin as one of the constituents and the identification of benzoic acid as a hydrolysis product of a polyphenolic ester.

AB - Extracts of Rumex hymenosepalus have shown antitumor activity against the Sarcoma 180 and Walker 256 test systems of the Cancer Chemotherapy National Service Center, Bethesda, Md. The extracts have been fractionated by means of solvent extraction and paper chromatography into two distinct fractions. The partial characterization of these fractions is described, including the characterization of leucocyanidin as one of the constituents and the identification of benzoic acid as a hydrolysis product of a polyphenolic ester.

UR - http://www.scopus.com/inward/record.url?scp=0013799368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0013799368&partnerID=8YFLogxK

U2 - 10.1002/jps.2600540933

DO - 10.1002/jps.2600540933

M3 - Article

C2 - 5881240

AN - SCOPUS:0013799368

SN - 0022-3549

VL - 54

SP - 1376

EP - 1378

JO - Journal of pharmaceutical sciences

JF - Journal of pharmaceutical sciences

IS - 9

ER -

Isolation of a potential antitumor fraction from Rumex hymenosepalus

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this